What is Rigel Pharmaceuticals's total revenue?

Rigel Pharmaceuticals (RIGL) reported total revenue of $58.82M in Q1 2026.

How has Rigel Pharmaceuticals's total revenue changed year-over-year?

Rigel Pharmaceuticals's total revenue increased by 10.3% year-over-year, from $53.33M to $58.82M.

What is the long-term trend for Rigel Pharmaceuticals's total revenue?

Over 4 years (2021 to 2025), Rigel Pharmaceuticals's total revenue has grown at a 18.5% compound annual growth rate (CAGR), from $149.24M to $294.28M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Rigel Pharmaceuticals RIGL Total Revenue

Total Revenue at other companies

AmgenAMGN

$8.62B+5.8%

Agios PharmaceuticalsAGIO

$20.75M+138%

Nuvation BioNUVB

$83.23M+2,599%

Zevra Therapeutics, Inc.ZVRA

$36.22M+77.5%

Eton Pharmaceuticals, Inc.ETON

$24.27M+40.4%

Theravance BiopharmaTBPH

$17.7M+15.0%

Segments

By product

See full

Gross product sales$75.39M+25.2%

Release Of Share Cost Liability$39.98M—

Discounts and allowances-$20.47M-23.0%

Delivery of drug supplies, royalties and others$3.9M-42.6%

Development Milestones$0-100%

By segment

See full

Single reportable segment$58.82M—

Other financials

Income statement

See full

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's total revenue?: Rigel Pharmaceuticals (RIGL) reported total revenue of $58.82M in Q1 2026.
How has Rigel Pharmaceuticals's total revenue changed year-over-year?: Rigel Pharmaceuticals's total revenue increased by 10.3% year-over-year, from $53.33M to $58.82M.
What is the long-term trend for Rigel Pharmaceuticals's total revenue?: Over 4 years (2021 to 2025), Rigel Pharmaceuticals's total revenue has grown at a 18.5% compound annual growth rate (CAGR), from $149.24M to $294.28M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.